Institute for Molecular Medicine Finland, HiLIFE
Institute for Molecular Medicine Finland, HiLIFE

FIMM at 15: EMBL in Finland Minisymposium

On May 27, 2022 FIMM warmly welcomes EMBL Director General Edith Heard to Finland and celebrates the occasion with an afternoon minisymposium capturing the unique translational impact that FIMM, EMBL and their partners have made in transforming Nordic science towards an international research hub. Welcome!

Building a bridge from discovery to medicine

OUR MISSION: FIMM is a translational institute with a driving mission to perform innovative research on patients and populations - utilizing molecular, genomic and health data – targeted towards understanding drivers of health and disease and delivering improvements to the safety, efficacy and efficiency of healthcare in Finland and beyond.

COVID-19 Research

Insights into how to better understand and treat COVID-19 are desperately needed. This page summarizes the FIMM efforts in contributing our researchers' expertise, technology and time to help to beat the COVID-19 pandemic.

FIMM on Twitter

Follow FIMM on Twitter for real-time news updates!

The Nordic EMBL Partnership is making more connections across nodes! @mims_umea group leader Johan Henriksson……